Fresenius Medical Care - 股票

Fresenius Medical Care 资产回报率 2024

Fresenius Medical Care 资产回报率

0.01

股票代码

FME.DE

ISIN

DE0005785802

WKN

578580

在2024年,Fresenius Medical Care的总资产收益率 (ROA)为0.01,较上一年的0.02 ROA增长了-21.92%

Fresenius Medical Care Aktienanalyse

Fresenius Medical Care在做什么?

Fresenius Medical Care AG is a globally leading company in the field of dialysis and kidney care. The company was founded in 1996 when Fresenius AG merged its dialysis business with the US company National Medical Care (NMC). Today, Fresenius Medical Care operates in over 120 countries and employs around 120,000 people. The company operates more than 3,900 dialysis centers worldwide and serves approximately 345,000 dialysis patients. The business model of Fresenius Medical Care aims to improve the lives of patients with chronic kidney diseases by offering high-quality dialysis treatments, kidney care products, and treatment technologies. Fresenius Medical Care provides its patients with a comprehensive range of products and services that range from diagnosis to treatment and enable individualized patient care. A core competency of Fresenius Medical Care is the development and manufacture of dialysis products and technologies. The company offers a wide range of dialysis machines and accessories that can be used to support dialysis care in hospitals, clinics, and dialysis centers. In addition, the company offers medical solutions tailored to the needs of dialysis patients, including artificial kidneys, dialysis filters, and other medical devices. Fresenius Medical Care also conducts extensive research and development activities to develop innovative technologies as well as products and services that can improve the lives of dialysis patients. In terms of diagnostic products, Fresenius Medical Care offers a variety of laboratory and testing solutions that are used to monitor dialysis patients and ensure timely diagnosis of complications and infections. The company also offers a comprehensive range of medical devices and accessories that can be used to support patients in home dialysis. Fresenius Medical Care operates in three business segments: dialysis products, dialysis services, and hospital products. In the dialysis products segment, the company is engaged in the development, manufacture, and distribution of dialysis machines and accessories. In the dialysis services segment, the company operates a variety of dialysis centers and provides dialysis treatments performed by a multidisciplinary team of professionals. The company also operates a network of laboratories that offer diagnostic solutions for dialysis patients. In the hospital products segment, Fresenius Medical Care offers a variety of medical devices and solutions that help improve the clinical care of patients, including apheresis systems, infusion systems, and patient monitors. Throughout its history, Fresenius Medical Care has received numerous awards and recognitions, including the Innovation Award of the state of Baden-Württemberg for the development of an automated dialysis machine that enables better treatment of dialysis patients through the combination of online monitoring systems and intelligent algorithms. Overall, Fresenius Medical Care AG offers a comprehensive range of products and services for dialysis patients and is a significant player in the field of kidney care. The company is committed to improving the quality of life for patients with chronic kidney diseases and driving the development of innovative technologies and methods to treat this disease. Fresenius Medical Care ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Fresenius Medical Care 按部门划分的营业额

在Fresenius Medical Care股票(DE0005785802,578580,FME.DE)的财务报告中,将其营收分为4个细分市场: 1. North America, 2. EMEA, 3. Asia-Pacific, 4. Latin America. Fresenius Medical Care 股票(WKN: 578580,ISIN: DE0005785802,Ticker-Symbol: FME.DE)是对于有意投资于Health Care行业的投资者来说的一个领先投资选择。

  • 70 % North America

  • 15 % EMEA

  • 11 % Asia-Pacific

  • 4 % Latin America

资产回报率的详细信息

Fresenius Medical Care的资本回报率(ROA)理解

Fresenius Medical Care的资本回报率(ROA)是一个关键指标,用于衡量公司相对于总资产的盈利能力。它通过将净利润除以总资产来计算。较高的ROA表明公司有效利用资产获取收益,反映了管理效率和财务健康状况。

年度对比

比较Fresenius Medical Care的年度ROA能提供关于公司运营效率和资产使用趋势的洞察。ROA的增加显示了改进的资产效率和盈利能力,而ROA的下降可能表明存在运营或财务挑战。

对投资的影响

投资者视Fresenius Medical Care的ROA为评估公司盈利能力和效率的关键指标。较高的ROA意味着公司有效地使用其资产以获取收益,这使其可能成为一个吸引人的投资目标。

解读ROA波动

Fresenius Medical Care的ROA波动可能是由于净利润、资产收购或运营效率的变化。分析这些波动有助于评估公司的财务表现,管理效率和战略财务定位。

关于Fresenius Medical Care股票的常见问题

Fresenius Medical Care今年的资产回报率(ROA)是多少?

Fresenius Medical Care今年的资产回报率(ROA)为0.01 undefined。

Fresenius Medical Care去年的ROA有多高?

Fresenius Medical Care的ROA与去年相比了-21.92%。

Fresenius Medical Care的投资者面临高ROA的后果是什么?

对于Fresenius Medical Care的投资者来说,高ROA是有利的,因为这表明公司有效地利用了其资产并获取了良好的收益。

Fresenius Medical Care的投资者低ROA会有什么后果?

对于Fresenius Medical Care的投资者来说,较低的ROA可能不利,因为这表明公司使用其资产的效率不高,可能会获得较低的利润。

Fresenius Medical Care的ROA提升对公司有何影响?

ROA的提升Fresenius Medical Care可能是资产利用效率提高和盈利能力增强的指标。

Fresenius Medical Care的ROA降低会对公司产生什么影响?

ROA下降Fresenius Medical Care可能是资产利用效率下降和盈利能力降低的指标。

Fresenius Medical Care的ROA可能受哪些因素影响?

影响Fresenius Medical Care的ROA的一些因素包括营业额、运营成本、资产结构和行业平均水平。

为什么Fresenius Medical Care的ROA对投资者来说很重要?

Fresenius Medical Care的ROA对投资者来说非常重要,因为它是衡量公司盈利能力和资产使用效率的指标。这可以向投资者提供信息,说明公司如何有效利用其资源来创造利润。

Fresenius Medical Care可以采取哪些战略措施来提高ROA?

为了提高Fresenius Medical Care的资产收益率(ROA),他们可以采取的措施包括节省成本、提高销售额、优化资产结构以及多样化业务活动。重要的是,公司需要对其财务状况进行深入审查,以确定最佳的战略措施来提高资产收益率。

Fresenius Medical Care支付多少股息?

在过去的12个月中,Fresenius Medical Care支付了1.12 EUR 的股息。这相当于大约3.14 %的股息收益率。在未来的12个月内,Fresenius Medical Care预计将支付1.14 EUR的股息。

Fresenius Medical Care的股息收益率有多高?

Fresenius Medical Care当前的股息收益率为3.14 %。

Fresenius Medical Care什么时候支付股息?

Fresenius Medical Care按季度支付股息。这些股息将在, , , 月份分发。

Fresenius Medical Care的股息有多安全?

Fresenius Medical Care 在过去33年里每年都支付了股息。

Fresenius Medical Care的股息有多高?

预计未来12个月的股息将达到1.14 EUR。这相当于3.2 %的股息收益率。

Fresenius Medical Care位于哪个行业?

Fresenius Medical Care 被分配到“健康”板块。

Wann musste ich die Aktien von Fresenius Medical Care kaufen, um die vorherige Dividende zu erhalten?

要获得Fresenius Medical Care在支付的1.19 EUR的最后一笔股息,你必须在的除息日之前持有该股票于你的账户中。

Fresenius Medical Care最后一次支付股息是什么时候?

上一次股息发放日期为。

Fresenius Medical Care在2023年的股息是多少?

在2023年,Fresenius Medical Care 分配了1.35 EUR作为股息。

Fresenius Medical Care 的股息是以哪种货币支付的?

Fresenius Medical Care的股息将以EUR的形式分配。

股票储蓄计划为投资者提供了一种吸引人的方法,可以长期累积财富。主要优势之一是所谓的成本平均效应:通过定期投入固定金额于股票或股票基金,当价格低时自动买入更多份额,价格高时买入较少,这可能随着时间带来更优惠的平均每份成本。此外,股票储蓄计划还允许小额投资者接触到高价股票,因为他们可以用很小的金额参与其中。定期投资也促进了一种纪律投资策略,并有助于避免情绪化的决策,如冲动买卖。除此之外,投资者还能从股票的潜在增值以及可以再投资的股息分红中获益,这增强了复利效应,从而增加了投资资本的增长。

Fresenius Medical Care 股票在以下供应商处可进行定投计划:Trade Republic, ING, Scalable Capital 与 Consorsbank

Andere Kennzahlen von Fresenius Medical Care

我们对Fresenius Medical Care 营业额股票的股票分析包括重要的财务指标,如收入、利润、市盈率、市销率、息税折旧摊销前利润,以及有关股息的信息。此外,我们还研究了诸如股票、市值、债务、股东权益和Fresenius Medical Care 营业额的负债等方面。如果您在寻找关于这些主题的更详细信息,我们在子页面上提供了详细的分析: